- Home
- NATR vs FHTX Comparison
NATR vs FHTX Comparison
Compare NATR & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NATR | FHTX |
|---|---|---|
| Founded | 1972 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 392.7M | 323.4M |
| IPO Year | 1995 | 2020 |
Fundamental Metrics
Financial Performance| Metric | NATR | FHTX |
|---|---|---|
| Price | $20.65 | $4.16 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 8 |
| Target Price | ★ $28.33 | $11.50 |
| AVG Volume (30 Days) | 113.8K | ★ 150.7K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 165.00 | 25.32 |
| EPS | ★ 0.29 | N/A |
| Revenue | ★ $480,144,000.00 | $30,909,000.00 |
| Revenue This Year | $7.76 | $8.89 |
| Revenue Next Year | $4.82 | $20.13 |
| P/E Ratio | $70.34 | ★ N/A |
| Revenue Growth | 5.67 | ★ 36.75 |
| 52 Week Low | $12.97 | $3.27 |
| 52 Week High | $28.14 | $6.95 |
Technical Indicators
Market Signals| Indicator | NATR | FHTX |
|---|---|---|
| Relative Strength Index (RSI) | 34.60 | 51.77 |
| Support Level | $19.38 | $3.59 |
| Resistance Level | $21.55 | $4.64 |
| Average True Range (ATR) | 0.74 | 0.25 |
| MACD | 0.11 | 0.05 |
| Stochastic Oscillator | 37.52 | 60.48 |
Price Performance
Historical ComparisonAbout NATR Nature's Sunshine Products Inc.
Natures Sunshine Products Inc is a natural health and wellness company mainly engaged in the manufacturing and direct selling of nutritional and personal care products. The following Companies' product lines include: General health: Assorted health products related to blood sugar, bone health, cellular health, etc. Immune: offer products that support and strengthen the human immune system, Cardiovascular: Ingredients to give the cardiovascular system optimum support. Digestive: regulates intestinal and digestive functions, Personal care: personal care products for external use, and Weight management: to simplify the weight management process by providing healthy meal replacements. Business segment: Asia, Europe, North America, Latin America, and Other. The majority of revenue is from Asia.
About FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.